GB9914026D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9914026D0
GB9914026D0 GBGB9914026.1A GB9914026A GB9914026D0 GB 9914026 D0 GB9914026 D0 GB 9914026D0 GB 9914026 A GB9914026 A GB 9914026A GB 9914026 D0 GB9914026 D0 GB 9914026D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914026.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9914026.1A priority Critical patent/GB9914026D0/en
Publication of GB9914026D0 publication Critical patent/GB9914026D0/en
Priority to PCT/GB2000/002308 priority patent/WO2000078736A1/en
Priority to JP2001504902A priority patent/JP2003502411A/en
Priority to EP00938921A priority patent/EP1192141A1/en
Priority to AU54144/00A priority patent/AU5414400A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9914026.1A 1999-06-17 1999-06-17 Chemical compounds Ceased GB9914026D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9914026.1A GB9914026D0 (en) 1999-06-17 1999-06-17 Chemical compounds
PCT/GB2000/002308 WO2000078736A1 (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents
JP2001504902A JP2003502411A (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents
EP00938921A EP1192141A1 (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents
AU54144/00A AU5414400A (en) 1999-06-17 2000-06-14 1,4-diazacycloheptane derivatives as neuroprotective agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914026.1A GB9914026D0 (en) 1999-06-17 1999-06-17 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9914026D0 true GB9914026D0 (en) 1999-08-18

Family

ID=10855476

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914026.1A Ceased GB9914026D0 (en) 1999-06-17 1999-06-17 Chemical compounds

Country Status (5)

Country Link
EP (1) EP1192141A1 (en)
JP (1) JP2003502411A (en)
AU (1) AU5414400A (en)
GB (1) GB9914026D0 (en)
WO (1) WO2000078736A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113908174B (en) * 2021-10-29 2022-06-24 北京四环制药有限公司 Efficient and safe preparation method and application of cerebroprotein hydrolysate
CN115112800B (en) * 2022-07-01 2023-07-07 河南润弘制药股份有限公司 Improved detection method for homopiperazine in fasudil hydrochloride injection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
DE69842058D1 (en) * 1997-10-27 2011-01-27 Neurosearch As Heteroaryl Diazacycloalkanes as cholinergic ligands for nicotine acetylcholine receptors
GB9726736D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Chemical compounds
AU1874500A (en) * 1998-12-24 2000-07-31 Astrazeneca Ab 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders

Also Published As

Publication number Publication date
JP2003502411A (en) 2003-01-21
WO2000078736A1 (en) 2000-12-28
EP1192141A1 (en) 2002-04-03
AU5414400A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9914025D0 (en) Chemical compounds
GB9914026D0 (en) Chemical compounds
GB9914024D0 (en) Chemical compounds
GB9914015D0 (en) Chemical compounds
GB9910394D0 (en) Chemical compounds
GB9914022D0 (en) Chemical compounds
GB9910419D0 (en) Chemical compounds
GB9908355D0 (en) Chemical compounds
GB9910405D0 (en) Chemical compounds
GB9909408D0 (en) Chemical compounds
GB9910673D0 (en) Chemical compounds
GB9910672D0 (en) Chemical compounds
GB9910647D0 (en) Chemical compounds
GB9910421D0 (en) Chemical compounds
GB9910675D0 (en) Chemical compounds
GB9910417D0 (en) Chemical compounds
GB9910409D0 (en) Chemical compounds
GB9912640D0 (en) Chemical compounds
GB9910396D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)